Silhouette

STEPHEN H. EMBURY

Vanguard Therapeutics, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy
Vanguard Therapeutics, Inc.
Principal Investigator
HHS 2 $1.68MM 09/21/17 08/31/18
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy
Vanguard Therapeutics, Inc.
Principal Investigator
HHS 2 $324K 09/01/17 08/31/18
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy
Vanguard Therapeutics, Inc.
Principal Investigator
HHS 2 $1.67MM 09/19/16 08/31/17
Reliable Assays for Pentosan Polysulfate Sodium
Vanguard Therapeutics, Inc.
Principal Investigator
HHS 1 $109K 05/15/15 07/31/15
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy
Vanguard Therapeutics, Inc.
Principal Investigator
HHS 1 $226K 08/01/14 01/31/15
Reliable Assays for Pentosan Polysulfate Sodium
Vanguard Therapeutics, Inc.
Principal Investigator
HHS 1 $204K 02/15/14 07/31/14